NZ537390A - 5-(1,3-oxazol-2-yl) benzoic acid derivatives useful in the preparation of compounds and pharmaceutical compositions useful for treating Alzheimer?s disease and related conditions - Google Patents

5-(1,3-oxazol-2-yl) benzoic acid derivatives useful in the preparation of compounds and pharmaceutical compositions useful for treating Alzheimer?s disease and related conditions

Info

Publication number
NZ537390A
NZ537390A NZ537390A NZ53739003A NZ537390A NZ 537390 A NZ537390 A NZ 537390A NZ 537390 A NZ537390 A NZ 537390A NZ 53739003 A NZ53739003 A NZ 53739003A NZ 537390 A NZ537390 A NZ 537390A
Authority
NZ
New Zealand
Prior art keywords
alkyl
optionally substituted
heteroaryl
aryl
groups
Prior art date
Application number
NZ537390A
Other languages
English (en)
Inventor
Michael R Reeder
Rick J Imbordino
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of NZ537390A publication Critical patent/NZ537390A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
NZ537390A 2002-06-20 2003-06-20 5-(1,3-oxazol-2-yl) benzoic acid derivatives useful in the preparation of compounds and pharmaceutical compositions useful for treating Alzheimer?s disease and related conditions NZ537390A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028502P 2002-06-20 2002-06-20
US45047803P 2003-02-27 2003-02-27
PCT/US2003/019585 WO2004000821A1 (en) 2002-06-20 2003-06-20 Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives

Publications (1)

Publication Number Publication Date
NZ537390A true NZ537390A (en) 2006-07-28

Family

ID=30003150

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ537390A NZ537390A (en) 2002-06-20 2003-06-20 5-(1,3-oxazol-2-yl) benzoic acid derivatives useful in the preparation of compounds and pharmaceutical compositions useful for treating Alzheimer?s disease and related conditions

Country Status (17)

Country Link
US (2) US7115747B2 (enExample)
EP (1) EP1532123B1 (enExample)
JP (1) JP2005533811A (enExample)
CN (1) CN1324017C (enExample)
AT (1) ATE370131T1 (enExample)
AU (1) AU2003249344A1 (enExample)
BR (1) BR0312439A (enExample)
CA (1) CA2489988A1 (enExample)
CO (1) CO5670350A2 (enExample)
DE (1) DE60315664D1 (enExample)
EA (1) EA008389B1 (enExample)
IL (1) IL165763A0 (enExample)
MX (1) MXPA04012630A (enExample)
NO (1) NO20045497L (enExample)
NZ (1) NZ537390A (enExample)
PL (1) PL374999A1 (enExample)
WO (1) WO2004000821A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0316629A (pt) * 2002-11-27 2005-10-11 Elan Pharm Inc Uréias e carbamatos substituìdos
TW200738701A (en) * 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
US7872009B2 (en) * 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
US7838676B2 (en) * 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
US7745484B2 (en) 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
EP1971598A1 (en) 2005-11-21 2008-09-24 Amgen Inc. Beta-secretase modulators and methods of use
WO2008137954A2 (en) * 2007-05-07 2008-11-13 Environmental Packaging Technologies Limited Universal shipping container
US8163909B2 (en) 2007-05-25 2012-04-24 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
JP5440984B2 (ja) * 2007-05-25 2014-03-12 アムジエン・インコーポレーテツド β−セクレターゼ修飾剤としての置換ヒドロキシエチルアミン化合物および使用方法
US7803809B2 (en) 2008-11-12 2010-09-28 Amgen Inc. Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
KR20110073511A (ko) 2008-09-11 2011-06-29 암젠 인크 베타세크레타제 조절제로서의 스피로-테트라사이클릭 고리 화합물 및 사용 방법
WO2011063233A1 (en) 2009-11-23 2011-05-26 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
EP2504330A1 (en) 2009-11-23 2012-10-03 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
CA2788363A1 (en) 2010-01-19 2011-07-28 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
JP5584352B2 (ja) 2010-03-15 2014-09-03 アムジエン・インコーポレーテツド β−セクレターゼ調節剤としてのアミノ−ジヒドロオキサジン系およびアミノ−ジヒドロチアジン系スピロ化合物ならびにそれらの医学的用途
CA2791281A1 (en) 2010-03-15 2011-09-22 Amgen Inc. Spiro-tetracyclic ring compounds as beta-secretase modulators
EP2673279A1 (en) 2011-02-07 2013-12-18 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use
EP2758406A1 (en) 2011-09-21 2014-07-30 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9725469B2 (en) 2012-11-15 2017-08-08 Amgen, Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US11272751B2 (en) 2016-03-01 2022-03-15 Nicholas Popejoy Protective headgear, impact diffusing systems and methods
US9462841B1 (en) 2016-03-01 2016-10-11 William Popejoy Protective headgear and shoulder pad apparatus and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020276A1 (es) * 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
CA2462851A1 (en) 2001-10-04 2003-04-10 Elan Pharmaceuticals, Inc. Hydroxypropylamines
AR039555A1 (es) * 2001-11-08 2005-02-23 Upjohn Co Derivados n,n'-sustituidos de 1,3-diamino-2-hidroxipropano
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
DE60315664D1 (de) 2007-09-27
CN1324017C (zh) 2007-07-04
EP1532123A1 (en) 2005-05-25
NO20045497D0 (no) 2004-12-16
NO20045497L (no) 2005-03-07
PL374999A1 (en) 2005-11-14
EA008389B1 (ru) 2007-04-27
CN1662510A (zh) 2005-08-31
MXPA04012630A (es) 2005-09-30
BR0312439A (pt) 2005-05-10
EP1532123B1 (en) 2007-08-15
AU2003249344A1 (en) 2004-01-06
US20070105921A1 (en) 2007-05-10
JP2005533811A (ja) 2005-11-10
CO5670350A2 (es) 2006-08-31
CA2489988A1 (en) 2003-12-31
HK1081543A1 (zh) 2006-05-19
IL165763A0 (en) 2006-01-15
ATE370131T1 (de) 2007-09-15
US7115747B2 (en) 2006-10-03
EA200401510A1 (ru) 2005-06-30
WO2004000821A1 (en) 2003-12-31
US20040063965A1 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
NZ537390A (en) 5-(1,3-oxazol-2-yl) benzoic acid derivatives useful in the preparation of compounds and pharmaceutical compositions useful for treating Alzheimer?s disease and related conditions
KR102238179B1 (ko) 아비박탐의 간단한 제조방법
WO2025103334A1 (zh) 一种多替诺雷制备方法及其应用
CA2660736A1 (en) Process and intermediates for the synthesis of 2-(quinolin-5-yl)-4,5 disubstituted-azole derivatives
KR102421025B1 (ko) 신규 트리틸 보호제
KR101216885B1 (ko) 10-데아세틸-n-데벤조일-파클리탁셀의 반합성 제조 방법
EP3807268B1 (en) Process for the preparation of lifitegrast
CN101084192B (zh) 维生素b6的制备
CN109574860B (zh) 一种制备维兰特罗的方法
CN110577490A (zh) 阿维巴坦中间体(2s,5s)-n-保护基-5-羟基-2-甲酸哌啶的合成方法
JPWO2019123994A1 (ja) 新規アルキルジフェニルメタン保護剤
CN116874394A (zh) 一种制备炔酰胺类化合物的方法
KR20050019766A (ko) 5-(1,3-옥사졸-2-일)벤조산 유도체의 제조 방법
CN106167457A (zh) 新型的天冬氨酸衍生物,它的制备方法及其在固相多肽合成中的用途
JP2022035954A (ja) N-Boc-ラクタム誘導体及びその製造方法、並びに、環状アミン誘導体の製造方法
Wang et al. Synthesis and biological activity of novel N‐tert‐butyl‐N, N′‐substitutedbenzoylhydrazines containing 2‐methyl‐3‐(triphenylgermanyl) propoxycarbonyl
CN110092753B (zh) 一种合成3-氮杂二环[4.1.0]庚烷-2-甲酸及其盐酸盐的制备方法
CN101128449A (zh) 制备多西他赛的方法
CN104876872A (zh) 一种制备1-叔丁氧基羰基-3-羟甲基吲唑的方法及应用
JP2025062330A (ja) グルコンアミド誘導体の製造方法
CN120329233A (zh) 乌帕替尼中间体的制备方法及其中间体
CN112538058A (zh) 含恶唑环砜类化合物的制备方法
HK1081543B (en) Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives
CN116693428A (zh) 一种三(对甲苯磺酰氧甲基)硝基甲烷的合成方法
JPH0347269B2 (enExample)

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)